

Empower your formulations. Accelerate your innovation.
We are Safic-Alcan France
Safic-Alcan France is part of the Safic-Alcan Group, a global distributor of specialty chemical ingredients. We support manufacturers, formulators and R&D teams by connecting ingredients, expertise and local market knowledge.
What we do
Safic-Alcan distributes specialty chemical ingredients across a wide range of industries, including life sciences and performance materials. We act as a link between suppliers and local markets, ensuring reliable access to ingredients, technical information and application support.
How we support customers
Beyond ingredient distribution, Safic-Alcan provides local commercial and technical support, access to formulation expertise, regulatory assistance and supply chain reliability. Our teams work closely with customers to support development, sourcing and market needs.
Our local presence in France
Safic-Alcan France combines the strength of a global group with local teams, stock and expertise. This local presence enables proximity to customers, fast response times and market-specific support.
Discover industry insights
See more insights
Antioxidants and Antiozonants in Rubber Formulation: Mechanisms, Families and Selection
Rubber compounds do not fail because of mechanical overload alone. Most service failures trace back to two chemical degradation pathways that are well understood, largely preventable, and still routinely underestimated at the formulation stage: thermal-oxidative aging and ozone cracking. These two processes are chemically distinct, operate on different timescales, and require different additive strategies. Antioxidants … <a href="https://www.safic-alcan.com/en-fr/industry-articles/antioxydants-antiozonants/">Continued</a>

How Modified-Release Tablets Work: A Plain-Language Primer for Pharma
A tablet that releases its drug over eight hours instead of two is not just a convenience. It maintains a more stable concentration in the bloodstream, reduces the number of doses a patient has to remember, and can avoid the peaks that cause side effects and the troughs that cause therapeutic failure. Modified-release technology makes this possible by controlling not just how much drug is delivered, but when, where, and at what rate. This article explains the main mechanisms used in modified-release oral solid dosage forms, the excipients that make them work, and the formulation logic behind each approach. It is written for pharmaceutical professionals who need a clear working understanding of the science rather than a textbook-level deep dive. What « modified release » actually means The term covers any oral dosage form where the rate, timing, or location of drug release has been deliberately altered from what would happen if the drug were simply compressed into a tablet with no release-controlling technology. Regulatory frameworks split this into two main categories: Some formulations combine both: a delayed start followed by extended delivery once release begins. Mechanism 1: Hydrophilic matrix tablets The hydrophilic matrix is the most widely used extended-release technology in … <a href="https://www.safic-alcan.com/en-fr/industry-articles/modified-release-tablets/">Continued</a>

Ionomer Resins for Luxury Packaging: A Surlyn® Guide
Quick answer: Surlyn® is an ionomer resin produced by Dow from a copolymer of ethylene and methacrylic acid, partially neutralized with sodium or zinc ions. It combines glass-like optical clarity, impact resistance, and chemical inertness in a single thermoplastic material, which explains its dominance in luxury fragrance caps, closures, and cosmetic jars. Two sustainable grades, … <a href="https://www.safic-alcan.com/en-fr/industry-articles/luxury-packaging-guide-surlyn/">Continued</a>
Learn more about Safic-Alcan France















